This article is a correction to:
Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice
Esraah Alharris1
Hasan Alghetaa1
Ratanesh Seth2
Saurabh Chatterjee2
Narendra P. Singh1
Mitzi Nagarkatti1
Prakash Nagarkatti1*- 1Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States
- 2Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, United States
A Corrigendum on
Resveratrol attenuates allergic asthma and associated inflammation in the lungs through regulation of miRNA-34a that targets FoxP3 in mice
by Alharris E, Alghetaa H, Seth R, Chatterjee S, Singh NP, Nagarkatti M and Nagarkatti P (2018) Front. Immunol. 9:2992. doi: 10.3389/fimmu.2018.02992
In the published article, there was an error in Figure 5B, Ova-veh 20X panel, as published. The wrong microscopy picture of immunohistochemistry was provided. The corrected Figure 5 and its caption appear below.
FIGURE 5
Figure 5 Resveratrol treatment leads to induction of FOXP3+ cells in the lungs: Immunofluorescence and immunohistochemistry were performed to determine the expression of FOXP3 in lung tissues and FoxP3 expression in the cells was assessed using corrected total cell fluorescence (CTCF) and ImageJ software. (A) Shows the expression of FOXP3 in lung tissues. The data in vertical bars represent Mean+/– SEM of 10 random spots analyzed. Significance (*p < 0.05) of FoxP3 expression between the groups was analyzed using Student’s t-test. (B) Shows FoxP3 expression in lung tissues by performing immunohistochemistry. The data represented as Mean+/– SEM of random 3–5 spots that were analyzed. The number of mice used (Naïve: n = 3, OVA-veh: n = 3, and OVA-res: n = 3). Significance (**p <0.01, ****p <0.0001) in FoxP3 expression was detected using one-way ANOVA and post-hoc Tukey’s test.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Asthma, resveratrol, miRNA-34a, Foxp3, T regulatory cells
Citation: Alharris E, Alghetaa H, Seth R, Chatterjee S, Singh NP, Nagarkatti M and Nagarkatti P (2023) Corrigendum: Resveratrol attenuates allergic asthma and associated inflammation in the lungs through regulation of miRNA-34a that targets FoxP3 in mice. Front. Immunol. 14:1130947. doi: 10.3389/fimmu.2023.1130947
Received: 23 December 2022; Accepted: 23 January 2023;
Published: 14 February 2023.
Edited and Reviewed by:
Raquel Hontecillas, Virginia Tech, United StatesCopyright © 2023 Alharris, Alghetaa, Seth, Chatterjee, Singh, Nagarkatti and Nagarkatti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Prakash Nagarkatti, cHJha2FzaEBtYWlsYm94LnNjLmVkdQ==